CB
CBD Life Sciences Inc.
CBDL · OTC
$0.00 -33.33% (-$0.00)
1M +100.00%
Market Cap $281.5K
P/E Ratio -
Div. Yield -
ROE 9.15%
Piotroski F-Score Weak
3/9Valuation
81 /100
Cheap P/S 2.86x
P/B 0.37x
P/E N/A
Growth
22 /100
Declining Rev. growth 15.03%
Book val. growth 17.46%
EPS growth N/A
Profitability
17 /100
Weak Gross margin 42.20%
Net margin 49.76%
Op. margin 103.44%
Quality
2 /100
Poor ROIC 13.26%
ROE 9.15%
ROA 6.08%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 15.12x
Int. coverage N/A
Stability
30 /100
Unstable Beta -0.59x
Rev. volatility 19.84%
EPS volatility 164.43%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CBDL
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Lisa Anne Nelson
Employees
3
Headquarters
Scottsdale